Should regulatory heads have regulatory experience?

Discussion in 'Amgen' started by Anonymous, Jan 19, 2011 at 8:34 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Let's look back the past half dozen regulatory heads. Have any had any pharma reg experience. Frightening to say but None. Would FDA hate AMgen if we had a reasonable experienced reghead?
     

  2. Anonymous

    Anonymous Guest

    The better question to be asked is whether Amgen should have hired someone fired from lilly to be SVP of RegSafety?
     
  3. Anonymous

    Anonymous Guest

    Your answer may depend on whether you measure success by the ability to obtain approval for dangerous drugs that ought not to ever have been approved or, instead, by "doing the right thing."
     
  4. Anonymous

    Anonymous Guest

    Everyone at amgen knows the answer to this question. The glaxo marketers want weak regsafety folk so that they can find no safety issues and avoid FDA. It's a sinister strategy to hire or assign unqualified people for leaders hip positions.
     
  5. Anonymous

    Anonymous Guest

    Whats so hard about regulatory. All you do is suck up to the fda and kick down to the team and don't let marketing say anything. Even a caveman could do it. Wait, cavemen are doing it in TO
     
  6. Anonymous

    Anonymous Guest

    "Should regulatory heads have regulatory experience?"

    Yes.
     
  7. Anonymous

    Anonymous Guest

    Guess out of the last 5 regualtory heads, how many had industry regulatory experience? You can include our current as he hasn;t.
     
  8. Anonymous

    Anonymous Guest

    None
     
  9. Anonymous

    Anonymous Guest

    Regulatory is easy work. Bend over and take it from FDA. Its so even, even a Paul can do it.
     
  10. Anonymous

    Anonymous Guest

    With so many regulatory failures, it's no wonder why dmab sales continue to be weak. Goldman is making millions shorting our stock down to the low 50s. Sick. Why can't we get Blankfein to run our company? We need the McKinsey consultants to step up and recommend to Kevin to hire some competent people.
     
  11. Anonymous

    Anonymous Guest

    Its not just Regulatory Affairs. One would think Amgen would want an endocrinologist or rheumatologist in Clinical Defelopment leading the bone programs - not a nephrologist!